Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of microarray technology in psychotropic drug trials.

Journal of psychopharmacology (Oxford, England) - 1 Jul 2006

Murphy Greer M

Abstract excerpt

Microarrays can be manufactured to detect hundreds of thousands of polymorphisms in DNA from patients in psychotropic drug trials. Some of these polymorphisms may be useful as pharmacogenetic predictors of treatment outcomes. We tested a microarray designed to detect common polymorphisms in the CYP2D6 gene that encodes debrisoquine hydroxylase (DH). DH is involved in the hepatic metabolism of many psychotropics....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Cytochrome P-450 CYP2D6
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Oligonucleotide Array Sequence Analysis

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Psychotropic Drugs

Source

Identifiers

PMID: 16785274
DOI: 10.1177/1359786806066059

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Application of microarray technology in psychotropic drug trials.PMID 16785274Read ↗

CYP2D6 genotyping with oligonucleotide microarrays and nortriptyline concentrations in geriatric depression.Semantic proximity Read ↗

DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping.Semantic proximity Read ↗

Clinical applications of microarray-based diagnostic tests.Semantic proximity Read ↗

Pharmacogenetics of antidepressant medication intolerance.Semantic proximity Read ↗

Polymorphisms in the CYP 2D6 gene: association with plasma concentrations of fluoxetine and paroxetine.Semantic proximity Read ↗

A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs.Semantic proximity Read ↗

Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics.Semantic proximity Read ↗

Prospective cytochrome P450 phenotyping for neuroleptic treatment in dementia.Semantic proximity Read ↗

Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.Semantic proximity Read ↗

Pharmacogenetics of desipramine metabolism.Semantic proximity Read ↗

No association between schizophrenia and polymorphisms within the genes for debrisoquine 4-hydroxylase (CYP2D6) and the dopamine transporter (DAT).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.